U.S. Markets for Respiratory Care Products
U.S. Markets for Respiratory Care Products
$4,750.00
The annual U.S. economic burden of respiratory disease is more than $106 billion. Appropriate therapy can reduce direct healthcare costs as well as indirect costs such as lost worker productivity. The combined U.S. market for respiratory products totalled more than $4.9 billion in 2015, and is expected to climb at a rate of 7% over the forecast period.
Publisher: Meddevicetracker
- Description
- Contents
- Samples
The annual U.S. economic burden of respiratory disease is more than $106 billion. Appropriate therapy can reduce direct healthcare costs as well as indirect costs such as lost worker productivity. The combined U.S. market for respiratory products totalled more than $4.9 billion in 2015, and is expected to climb at a rate of 7% over the forecast period. The sleep apneamanagement products market (including PAP products and accessories) is expected to experience the most dollar sales ($2.2 billion in 2015), as well as the greatest growth over the forecast period (8%). In the blood gas monitoring systems market, the increasing popularity of POC analyzershas led to the rapid emergence of technological innovation, resulting in the introduction of lighter, more compact, less costly systems. POC systems currently account for nearly 40% of the overall U.S. blood gas analyzersmarket.
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the U.S. ventilator systems, blood gas monitoring systems, pulmonary function assessment products, sleep apneamanagement products, and airway management accessories markets.
EXECUTIVE SUMMARY …………………………………………………………………………. ES-1
i. Ventilator systems ……………………………………………………………….. ES-1
ii. Blood gas monitoring systems ……………………………………………….. ES-3
iii. Pulmonary function assessment products ……………………………….. ES-9
iv. Sleep apnea management products ……………………………………… ES-10
v. Airway management accessories …………………………………………. ES-14
vi. Combined market discussion ………………………………………………. ES-18
vii. Methodology ……………………………………………………………………… ES-23
Exhibit ES-1: Ventilators, market forecast, 2015–20 …………………………………….. ES-4
Exhibit ES-2: Blood gas monitoring systems, market forecast, 2015–20 …………. ES-7
Exhibit ES-3: Pulmonary function assessment products, market forecast, 2015–20 …………………………………………………………………………… ES-11
Exhibit ES-4: Sleep apnea management products, market forecast, 2015–20 .. ES-15
Exhibit ES-5: Airway management accessories, market forecast, 2015–20 …… ES-19
Exhibit ES-6: Respiratory care products, combined market forecast, 2015–20 . ES-21
1. RESPIRATORY DISEASE OVERVIEW ……………………………………………… 1-1
1.1 Acute respiratory distress syndrome …………………………………………. 1-1
1.1.1 Etiology…………………………………………………………………… 1-2
1.1.2 Epidemiology …………………………………………………………… 1-3
1.2 Asthma …………………………………………………………………………………. 1-5
1.2.1 Etiology…………………………………………………………………… 1-5
1.2.2 Epidemiology …………………………………………………………… 1-5
1.3 Chronic obstructive pulmonary disease ……………………………………… 1-6
1.3.1 Chronic bronchitis …………………………………………………….. 1-6
1.3.1.1 Etiology ……………………………………………………. 1-6
1.3.2 Emphysema ……………………………………………………………. 1-8
1.3.2.1 Etiology ……………………………………………………. 1-9
1.3.3 Epidemiology …………………………………………………………… 1-9
1.4 Cystic fibrosis ………………………………………………………………………. 1-11
1.4.1 Etiology…………………………………………………………………. 1-11
1.4.2 Epidemiology …………………………………………………………. 1-11
1.5 Pneumonia ………………………………………………………………………….. 1-12
1.5.1 Etiology…………………………………………………………………. 1-12
1.5.2 Epidemiology …………………………………………………………. 1-14
1.6 Respiratory failure ………………………………………………………………… 1-14
1.6.1 Etiology…………………………………………………………………. 1-14
1.6.2 Epidemiology …………………………………………………………. 1-14
1.7 Restrictive lung disease …………………………………………………………. 1-16
1.7.1 Etiology…………………………………………………………………. 1-16
1.7.2 Epidemiology …………………………………………………………. 1-18
1.8 Sleep apnea ………………………………………………………………………… 1-20
1.8.1 Etiology…………………………………………………………………. 1-20
1.8.2 Epidemiology …………………………………………………………. 1-20
1.9 Tuberculosis ………………………………………………………………………… 1-21
1.9.1 Etiology…………………………………………………………………. 1-21
1.9.2 Epidemiology …………………………………………………………. 1-23
Exhibit 1-1: Acute respiratory distress syndrome, selected facts and figures ……. 1-4
Exhibit 1-2: Asthma, selected facts and figures ……………………………………………. 1-7
Exhibit 1-3: Chronic obstructive pulmonary disease, selected facts and figures 1-10
Exhibit 1-4: Cystic fibrosis, selected facts and figures …………………………………. 1-13
Exhibit 1-5: Pneumonia, selected facts and figures …………………………………….. 1-15
Exhibit 1-6: Respiratory failure, selected facts and figures …………………………… 1-17
Exhibit 1-7: Restrictive lung disease, selected facts and figures …………………… 1-19
Exhibit 1-8: Obstructive sleep apnea, selected facts and figures ………………….. 1-22
Exhibit 1-9: Tuberculosis, selected facts and figures …………………………………… 1-24
2. VENTILATORS MARKET …………………………………………………………………. 2-1
2.1 Types of mechanical ventilators ……………………………………………….. 2-2
2.1.1 High-frequency ventilation …………………………………………. 2-2
2.1.2 Noninvasive ventilation ……………………………………………… 2-2
2.2 Market analysis ……………………………………………………………………… 2-6
2.2.1 Adult and pediatric ventilators ………………………………….. 2-11
2.2.1.1 Market forecast ………………………………………… 2-11
2.2.1.2 Competitive analysis ………………………………… 2-12
2.2.2 Neonatal ventilators ………………………………………………… 2-15
2.2.2.1 Market forecast ………………………………………… 2-17
2.2.2.2 Competitive analysis ………………………………… 2-18
2.2.3 Transport ventilators ……………………………………………….. 2-20
2.2.3.1 Market forecast ………………………………………… 2-20
2.2.3.2 Competitive analysis ………………………………… 2-22
Exhibit 2-1: Advantages and disadvantages of mechanical ventilation ……………. 2-3
Exhibit 2-2: Comparison of high-frequency ventilation modes ………………………… 2-4
Exhibit 2-3: Advantages and disadvantages of noninvasive ventilation ……………. 2-7
Exhibit 2-4: Ventilators, combined market forecast, 2015–20 ………………………. 2-10
Exhibit 2-5: Adult and pediatric ventilators, market forecast, 2015–20 …………… 2-13
Exhibit 2-6: Adult and pediatric ventilators market, share by supplier, 2015 …… 2-16
Exhibit 2-7: Neonatal ventilators, market forecast, 2015–20 ………………………… 2-19
Exhibit 2-8: Neonatal ventilators market, share by supplier, 2015 …………………. 2-21
Exhibit 2-9: Transport ventilators, market forecast, 2015–20 ……………………….. 2-23
Exhibit 2-10: Transport ventilators market, share by supplier, 2015 ………………… 2-25
3. BLOOD GAS MONITORING SYSTEMS MARKET ………………………………. 3-1
3.1 Market analysis ……………………………………………………………………… 3-1
3.1.1 Point-of-care blood gas analyzers ………………………………. 3-2
3.1.1.1 Market forecast ………………………………………….. 3-2
3.1.1.2 Competitive analysis ………………………………….. 3-6
3.1.2 Laboratory blood gas analyzers …………………………………. 3-8
3.1.2.1 Market forecast ………………………………………….. 3-8
3.1.2.2 Competitive analysis ………………………………… 3-10
3.1.3 Arterial blood gas sampling kits ………………………………… 3-10
3.1.3.1 Market forecast ………………………………………… 3-12
3.1.3.2 Competitive analysis ………………………………… 3-12
3.1.4 Oxygen monitoring products …………………………………….. 3-14
3.1.4.1 Market forecast ………………………………………… 3-16
3.1.4.2 Competitive analysis ………………………………… 3-17
3.1.5 Pulse oximeters ……………………………………………………… 3-19
3.1.5.1 Market forecast ………………………………………… 3-20
3.1.5.2 Competitive analysis ………………………………… 3-22
3.1.6 Capnography/end-tidal carbon dioxide monitoring products ………………………………………………… 3-23
3.1.6.1 Market forecast ………………………………………… 3-25
3.1.6.2 Competitive analysis ………………………………… 3-26
Exhibit 3-1: Blood gas monitoring systems, combined market forecast, 2015–20 ……………………………………………………………………………….. 3-3
Exhibit 3-2: Point-of-care blood gas analyzers, market forecast, 2015–20 ……….. 3-5
Exhibit 3-3: Point-of-care blood gas analyzers market, share by supplier, 2015 . 3-7
Exhibit 3-4: Laboratory blood gas analyzers, market forecast, 2015–20 ………….. 3-9
Exhibit 3-5: Laboratory blood gas analyzers market, share by supplier, 2015 .. 3-11
Exhibit 3-6: Arterial blood gas sampling kits, market forecast, 2015–20 ………… 3-13
Exhibit 3-7: Arterial blood gas sampling kits market, share by supplier, 2015 … 3-15
Exhibit 3-8: Oxygen monitoring products, market forecast, 2015–20 …………….. 3-18
Exhibit 3-9: Pulse oximeters, market forecast, 2015–20 ……………………………… 3-21
Exhibit 3-10: Pulse oximeters market, share by supplier, 2015 ………………………. 3-24
Exhibit 3-11: Capnography/end-tidal carbon dioxide monitoring products, market forecast, 2015–20 ………………………………………………………. 3-27
Exhibit 3-12: Capnography/end-tidal carbon dioxide monitoring products market, share by supplier, 2015 …………………………………………………………. 3-29
4. PULMONARY FUNCTION ASSESSMENT PRODUCTS MARKET ………… 4-1
4.1 Market analysis ……………………………………………………………………… 4-3
4.1.1 Diagnostic spirometers ……………………………………………… 4-4
4.1.1.1 Products and technology …………………………….. 4-8
4.1.1.2 Market forecast ………………………………………….. 4-8
4.1.1.3 Competitive analysis ………………………………….. 4-9
4.1.2 Pulmonary function testing systems ………………………….. 4-13
4.1.2.1 Products and technology …………………………… 4-13
4.1.2.2 Market forecast ………………………………………… 4-16
4.1.2.3 Competitive analysis ………………………………… 4-16
4.1.3 Pulmonary exercise testing equipment ………………………. 4-18
4.1.3.1 Products and technology …………………………… 4-21
4.1.3.2 Market forecast ………………………………………… 4-21
4.1.3.3 Competitive analysis ………………………………… 4-22
Exhibit 4-1: Lung volumes and capacities …………………………………………………… 4-2
Exhibit 4-2: Pulmonary function assessment products, combined market forecast, 2015–20 …………………………………………………………………… 4-5
Exhibit 4-3: Principal values measured via spirometry ………………………………….. 4-7
Exhibit 4-4: Diagnostic spirometers and disposables, market forecast, 2015–20 ……………………………………………………………………………… 4-10
Exhibit 4-5: Diagnostic spirometers and disposables market, share by supplier, 2015 …………………………………………………………………………………… 4-12
Exhibit 4-6: Indications for pulmonary function testing ………………………………… 4-14Exhibit 4-7: Pulmonary function testing equipment and disposables, market forecast, by type, 2015–20 ………………………………………….. 4-17
Exhibit 4-8: Pulmonary function testing equipment and disposables market, share by supplier, 2015 …………………………………………………………. 4-19
Exhibit 4-9: Pulmonary exercise testing and metabolic assessment equipment, market forecast, by type, 2015–20 ………………………………………….. 4-23
Exhibit 4-10: Pulmonary exercise testing and metabolic assessment equipment market, share by supplier, 2015 ……………………………………………… 4-26
5. SLEEP APNEA MANAGEMENT PRODUCTS MARKET ………………………. 5-1
5.1 Obstructive sleep apnea ………………………………………………………….. 5-1
5.2 Market analysis ……………………………………………………………………… 5-2
5.2.1 Obstructive sleep apnea monitoring products ………………. 5-2
5.2.1.1 Products and technology …………………………….. 5-5
5.2.1.2 Market analysis …………………………………………. 5-6
5.2.1.3 Competitive analysis ………………………………….. 5-6
5.2.2 Polysomnography products ……………………………………….. 5-8
5.2.2.1 Products and technology …………………………… 5-11
5.2.2.2 Market analysis ……………………………………….. 5-11
5.2.2.3 Competitive analysis ………………………………… 5-12
5.2.3 Obstructive sleep apnea treatment products ………………. 5-14
5.2.3.1 Products and technology …………………………… 5-14
5.2.3.2 Market analysis ……………………………………….. 5-16
5.2.3.3 Competitive analysis ………………………………… 5-17
Exhibit 5-1: Sleep apnea management products, combined market forecast, 2015–20 ……………………………………………………………………………….. 5-3
Exhibit 5-2: Obstructive sleep apnea monitoring products, market forecast, 2015–20 ……………………………………………………………………………….. 5-7
Exhibit 5-3: Obstructive sleep apnea monitoring products market, share by supplier, 2015 …………………………………………………………… 5-9
Exhibit 5-4: Polysomnography products, market analysis, 2015–20 ……………… 5-13
Exhibit 5-5: Polysomnography products market, share by supplier, 2015 ………. 5-15
Exhibit 5-6: Obstructive sleep apnea therapy products, market forecast, 2015–20 ……………………………………………………………………………… 5-18
Exhibit 5-7: Obstructive sleep apnea therapy products market, share by supplier, 2015 …………………………………………………………. 5-20
6. AIRWAY MANAGEMENT ACCESSORIES MARKET ………………………….. 6-1
6.1 Market analysis ……………………………………………………………………… 6-1
6.1.1 Heat and moisture exchangers …………………………………… 6-1
6.1.1.1 Products and technology …………………………….. 6-4
6.1.1.2 Market analysis …………………………………………. 6-4
6.1.1.3 Competitive analysis ………………………………….. 6-5
6.1.2 Humidifiers ……………………………………………………………… 6-7
6.1.2.1 Products and technology …………………………….. 6-9
6.1.2.2 Market analysis ……………………………………….. 6-10
6.1.2.3 Competitive analysis ………………………………… 6-11
6.1.3 Nebulizers …………………………………………………………….. 6-13
6.1.3.1 Large-volume nebulizers …………………………… 6-13
6.1.3.1.1 Products and technology ……….. 6-15
6.1.3.1.2 Market analysis …………………….. 6-15
6.1.3.1.3 Competitive analysis ……………… 6-15
6.1.3.2 Small-volume nebulizers …………………………… 6-17
6.1.3.2.1 Products and technology ……….. 6-17
6.1.3.2.2 Market analysis …………………….. 6-19
6.1.3.2.3 Competitive analysis ……………… 6-19
6.1.3.3 Nebulizer compressors ……………………………… 6-21
6.1.3.3.1 Products and technology ……….. 6-21
6.1.3.3.2 Market analysis …………………….. 6-21
6.1.3.3.3 Competitive analysis ……………… 6-23
6.1.4 Respiratory masks ………………………………………………….. 6-26
6.1.4.1 Products and technology …………………………… 6-26
6.1.4.2 Market analysis ……………………………………….. 6-27
6.1.4.3 Competitive analysis ………………………………… 6-27
Exhibit 6-1: Airway management accessories, combined market forecast, 2015–20 ……………………………………………………………………………….. 6-2
Exhibit 6-2: Heat and moisture exchangers, market forecast, 2015–20 …………… 6-6
Exhibit 6-3: Heat and moisture exchangers market, share by supplier, 2015 ……. 6-8
Exhibit 6-4: Humidifiers, market forecast, 2015–20 …………………………………….. 6-12
Exhibit 6-5: Humidifiers market, share by supplier, 2015 …………………………….. 6-14
Exhibit 6-6: Large-volume nebulizers, market forecast, 2015–20 ………………….. 6-16
Exhibit 6-7: Large-volume nebulizers market, share by supplier, 2015 ………….. 6-18
Exhibit 6-8: Small-volume nebulizers, market forecast, 2015–20 ………………….. 6-20Exhibit 6-9: Small-volume nebulizers market, share by supplier, 2015 ………….. 6-22
Exhibit 6-10: Nebulizer compressors, market forecast, 2015–20 ……………………. 6-24
Exhibit 6-11: Nebulizer compressors market, share by supplier, 2015 …………….. 6-25
Exhibit 6-12: Respiratory masks, market forecast, 2015–20 ………………………….. 6-28
Exhibit 6-13: Respiratory masks market, share by supplier, 2015 …………………… 6-30
APPENDIX A: COMPANY LISTING ………………………………………………………….. A-1
APPENDIX B: BIBLIOGRAPHY ……………………………………………………………….. B-1
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Semaglutide (Injectable) 
Sign up to the